Infants with and without CLD (development cohort)1-150
| No CLD n=29 | CLD n=26 | p Value | |
|---|---|---|---|
| Birthweight (g) | 1184 (718-2256) | 745 (580-1538) | < 0.0001 |
| Gestational age (weeks) | 29 (25-31) | 26 (23-31) | < 0.0001 |
| Antenatal steroids | 21 (72) | 23 (88) | 0.25 |
| Prophylactic indomethacin | 3 (10) | 8 (31) | 0.12 |
| Male sex | 15 (52) | 14 (54) | 1.0 |
| FIO2 (%) | 34 (21-100) | 58 (23-100) | 0.0001 |
| a:A ratio | 0.29 (0.04-0.67) | 0.16 (0.06-0.50) | 0.001 |
| PIP (cm H2O) | 14 (10-24) | 16 (12-29) | 0.12 |
| AT:RVET(c) | 0.47 (0.41-0.53) | 0.44 (0.37-0.51) | 0.0004 |
| pH | 7.34 (7.16-7.41) | 7.26 (7.10-7.41) | 0.0002 |
| PO2 (mm Hg) | 55 (27-132) | 54 (38-86) | 0.71 |
| PCO2 (mm Hg) | 38 (28-68) | 45 (35-63) | 0.0007 |
| Symptomatic PDA | 2 (7) | 7 (27) | 0.10 |
↵1-150 Results expressed as median (range) or number (%).